Keyphrases
Duchenne muscular Dystrophy
100%
Spinal muscular Atrophy
31%
Muscle Biopsy
24%
Vamorolone
23%
Hypotonia
21%
Duchenne
19%
Muscle Strength
19%
Prednisone
19%
Glucocorticoid Therapy
17%
Muscle Weakness
17%
Myopathy
17%
Mouse Model
16%
Myopathic
14%
Congenital muscular Dystrophy
14%
Disease Progression
14%
Seizure
14%
Congenital Myopathy
13%
Israel
13%
Ataluren
13%
Emery-Dreifuss muscular Dystrophy
12%
Clinical Characteristics
12%
Autosomal Recessive
12%
Electroencephalography
12%
Nonsense mutation Duchenne muscular Dystrophy
12%
Partial Seizures
11%
Israeli
11%
Randomized Controlled Trial
11%
Natural History Study
11%
Skeletal muscle
11%
Placebo
11%
Headache
10%
Pulmonary Function Test
10%
Prednisolone
10%
Intellectual Disability
10%
HyperCKemia
10%
Nusinersen
10%
Regeneration
10%
Fibrosis
9%
Pediatric Patients
9%
6-minute Walk Distance (6MWD)
9%
Muscular Dystrophy
9%
Integrin
9%
Motor Delay
9%
Onasemnogene Abeparvovec
9%
Deflazacort
9%
Muscle Pathology
8%
Child Development Center
8%
Tel Aviv
8%
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
8%
Epidemiology
8%
Medicine and Dentistry
Duchenne Muscular Dystrophy
51%
Diseases
22%
Spinal Muscular Atrophy
17%
Hypotonia
15%
Vamorolone
15%
Epileptic Seizure
15%
Headache
14%
Muscle Biopsy
14%
Glucocorticoid
14%
Muscular Dystrophy
11%
Placebo
11%
Pediatrics
10%
Muscle Strength
9%
Merosin
9%
Fibrosis
8%
Clinical Trial
8%
Prednisone
8%
Cohort Effect
8%
Muscle Weakness
8%
Central Nervous System
7%
Polyradiculoneuropathy
7%
Globoid Cell Leukodystrophy
7%
Failure to Thrive
7%
COVID-19
7%
Ataluren
7%
Nonsense Mutation
7%
C2C12
7%
Nerve Growth Factor
7%
Integrin
7%
Developmental Disorder
7%
Weakness
7%
Peripheral Nervous System
7%
Cerebrospinal Fluid
7%
Disease Exacerbation
7%
Partial Seizure
6%
Motor Performance
6%
Skeletal Muscle
6%
Pediatric Neurology
6%
Nusinersen
6%
Infantile Spasm
6%
Neuropathy
6%
Upper Limb
5%
Disease Course
5%
Lung Function Test
5%
Missense Mutation
5%
Scapula
5%
Dystrophin
5%
Becker Muscular Dystrophy
5%
Onasemnogene Abeparvovec
5%
Magnetic Resonance Imaging
5%